UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049199
Receipt number R000056038
Scientific Title A study on the effect of SNR16 intake during the follicular phase on skin condition -A Randomized, Open-Label, No Intake Controlled, Crossover Study-
Date of disclosure of the study information 2023/10/24
Last modified on 2023/09/08 09:17:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the effect of SNR16 intake during the follicular phase on skin condition

Acronym

A study on the effect of SNR16 intake during the follicular phase on skin condition

Scientific Title

A study on the effect of SNR16 intake during the follicular phase on skin condition
-A Randomized, Open-Label, No Intake Controlled, Crossover Study-

Scientific Title:Acronym

A study on the effect of SNR16 intake during the follicular phase on skin condition
-A Randomized, Open-Label, No Intake Controlled, Crossover Study-

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of SNR16 ingestion during the follicular phase on skin condition from multiple perspectives, using the non-ingested phase as a control. In addition, we will obtain basic information on skin condition and blood parameter variations between the follicular and luteal phases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Perception of skin condition

Key secondary outcomes

Skin Moisture Content
Skin Moisture Evaporation
Skin smoothness
Skin roughness
Scaling
Wrinkles


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Oral ingestion of SNR16
(1 pack per day for 6 days during follicular phase)

Interventions/Control_2

No intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

[1] Those who experience changes in skin condition according to their menstrual cycle.
[2] Those with regular menstrual cycles (26-35 days).
[3] Those who are able to consume the test foods, participate in necessary examinations, and answer questionnaires according to the schedule instructed by the researcher.

Key exclusion criteria

[1] Those who may show severe allergic symptoms to foods (especially soybeans, gelatin, oranges).
[2] Habitual users of health foods or supplements containing vitamin D within 1 month of study entry.
[3] Those who have undergone cosmetic procedures (cosmetic surgery, collagen injection, laser, hair removal, etc.) within 6 months of the start of the examination.
[4] Those who are exposed to excessive ultraviolet rays, such as those who work outdoors for long hours on a daily basis.
[5] Those whose BMI deviates from 18.5 to 25.
[6] Pregnant or lactating mothers, or those who wish to become pregnant during the study period.
[7] Those who have some kind of chronic disease and are receiving drug treatment.
[8] Persons who are judged to be inappropriate as subjects by the principal investigator and the principal investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Nakazima

Organization

Ueno-Asagao Clinic

Division name

Head

Zip code

110-0015

Address

2-7-5, Higashiueno, Taito-ku, Tokyo

TEL

03-6240-1162

Email

info@ueno-asagao.clinic


Public contact

Name of contact person

1st name Ryoma
Middle name
Last name Shimizu

Organization

TES Holdings CO., Ltd.

Division name

Administrative Department of Clinical Trials

Zip code

110-0015

Address

2-7-5, Higashiueno, Taito-ku, Tokyo

TEL

03-6801-8480

Homepage URL


Email

r.shimizu@tes-h.co.jp


Sponsor or person

Institute

TES Holdings CO., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ueno-Asagao Clinic Ethical Review Committee

Address

2-7-5, Higashiueno, Taito-ku, Tokyo

Tel

03-6240-1162

Email

jimukyoku@tes-h.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 09 Month 14 Day

Date of IRB

2022 Year 09 Month 15 Day

Anticipated trial start date

2022 Year 10 Month 24 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 12 Day

Last modified on

2023 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056038